Octreotide Slows Neuroendocrine Tumor Growth
Citation: Rinke A Müller HH, Schade-Brittinger, et al. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol. 2009;27:4656-4663. Abstract